Unison Advisors’s Pediatrix Medical MD Stock Holding History

Unison Advisors’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,914	Closed	-$178K	–	191
2020 Q3	$178K	Hold	10,914	–	–	0.05%	141
2020 Q2	$187K	Hold	10,914	–	–	0.06%	129
2020 Q1	$127K	Hold	10,914	–	–	0.14%	123
2019 Q4	$304K	Hold	10,914	–	–	0.22%	102
2019 Q3	$247K	Buy	+10,914	New	+$249K	0.19%	127
2018 Q4	–	Sell	-6,313	Closed	-$294K	–	172
2018 Q3	$294K	Hold	6,313	–	–	0.21%	116
2018 Q2	$274K	Buy	+6,313	New	+$302K	0.2%	131

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

Unison Advisors's MD Position: Q4 2020 in Review

Unison Advisors sold out of Pediatrix Medical (MD) in Q4 2020, closing a stake of 10,914 shares — an estimated $178K sold.

Unison Advisors first reported a position in MD in Q2 2018 and held it in 7 quarters. The position peaked at $304K in Q4 2019. 201 funds tracked by Wall St. Rank hold MD as of Q4 2020.

Unison Advisors reported no remaining Pediatrix Medical position as of Q4 2020 after selling out during the quarter.
Unison Advisors sold 10,914 Pediatrix Medical shares in Q4 2020, an estimated $178K.
Unison Advisors first reported a position in Pediatrix Medical in Q2 2018 and held it in 7 quarters.
Unison Advisors's Pediatrix Medical position peaked at $304K in Q4 2019.
201 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2020.

Based on Unison Advisors's 13F filing for Q4 2020, filed 19 Jan 2021.